We reasoned if GLS2 activity is indeed essential for glutamine-dependent anapleurosis in MYCN-amplified neuroblastoma cells, then, GLS2 suppression should recapitulate glutamine deprivation in regulation of glucose metabolism. The gene discussed is MYCN; the disease is neuroblastoma.